SWG Educational Activities

EHA-SWG meetings held in the past calendar year:

  • International Workshop on Biomarkers in Chronic Lymphocytic Leukemia: The Art of Synthesis
    Belgrade, Serbia (16-17 March  2018)

Chair: Kostas Stamatopoulos
Goal: Guidelines for diagnosis, indications for treatment, response assessment and supportive management of chronic lymphocytic leukemia.

  • International Workshop Biomarker-Guided Management of Chronic Lymphocytic Leukemia
    Moscow, Russia (13 April 2018)  

Chair: Kostas Stamatopoulos
Goal: To educate the audience on theoretical and practical aspects of IG and TP53 mutational analysis and cytogenetics

  • ERIC Workshop on IG Analysis
    Tel-Aviv, Israel  (04 July 2018)

Chair: Paolo Ghia
Goal: To educate the audience on the role of biomarkers in CLL.

SWG sessions at EHA congress:

  • 45th General Assembly of ERIC Members at the 23rd Congress of EHA
    Stockholm, Sweden (14 June 2018)  

Chair: Paolo Ghia
Goal: To provide ERIC Members with an update on ERIC activities and ongoing projects/announcements.

  • ERIC Scientific Workshop at the 23rd Congress of EHA
    Stockholm, Sweden

Invited lectures:

  • 41th Annual conference of Mumbai Hematology group, Mumbai (India), 14 March 2018. ERIC presentations in front of 30 hematologists from India.
  • Taiwan Hematological Working Group, Taipei (Taiwan, 2 April 2018). ERIC presentation in front of 20 haematologists from Taiwan.

Presentations at national and international meetings:

  • Late breaking abstract at the 23rd Congress of EHA
    Stockholm, Sweden

Title: Half of Chronic Lymphocytic Leukemia Patients Relapsing onder Ibrutinib Carry Btk and Plcg2 Mutations: A European Research Initiative on Cll (Eric) Real-World Study

Presenter: Lydia Scarfò, MD

Clinical trials promoted by or involving the SWG:

  • Retrospective observational study exploring the efficacy of bendamustine and rituximab in first line treatment in CLL

Collaborations on international projects promoted by or involving the SWG:

  • The role of Complex caryotype in predicting clinical outcome and comparison of screening assays to detect it.

Grants received by SWG related networks or principal investigators:

  • ERIC is a partner in the H2020 Harmony project “Big Data to enable better and faster treatment for Patients with Hematological Malignancies”.